To make things easier, leave this box checked On shared devices, we recommend that you disconnect from Euroquity when you are done
Email

You will receive an email to define a new password

Location

Select your country

and your language

Hi ,

Welcome to your personnel profile page! Fill in your information in order to become more visible to organizations that interest you.

% completed

%

NANOFABER srl_media
medal 1
This profile is validated by 1 label.

Company

NANOFABER srl

NANOFABER srl_logo
15
EQ SCORE

The EQ Score shows the company's activity and appeal on the platform: profile completeness, news, likes, follows, membership in one or more labels or communities, number of members in its network, etc.

Nanofaber’s mission is to overcome the challenges in current treatment of articular diseases and embrace the new paradigm of precision medicine, by means of its patented “Microsponge” drug delivery system.

Roma, Lazio, Italy

Send a message

English

NANOFABER srl

English

Nanofaber’s mission is to overcome the challenges in current treatment of articular diseases and embrace the new paradigm of precision medicine,  by means of its patented “Microsponge” drug delivery system. The ambition is to become a leading provider in the rheumatology field providing a high-performance, safe, low-cost and easy to use long-lasting injection product to deliver drugs & biologics directly into the intra-articular site. Apart from reducing the frequency of painful...

See more

Nanofaber’s mission is to overcome the challenges in current treatment of articular diseases and embrace the new paradigm of precision medicine,  by means of its patented “Microsponge” drug delivery system. The ambition is to become a leading provider in the rheumatology field providing a high-performance, safe, low-cost and easy to use long-lasting injection product to deliver drugs & biologics directly into the intra-articular site. Apart from reducing the frequency of painful injections for patients, Microsponge will address the need of physicians and patients struggling with side-effects and burden on intra-articular injections. Rheumatology is an entry point into the market and, eventually, Microsponge would expand its field of applications to the entire medicine.

Initially, Microsponge will be industrialized and clinically validated for treating osteoarthrosis, aiming at a GMP-compliant manufacturing system and validated clinical protocols, enough to spear-head commercialization and licensing to the over 130 pharmaceutical and biotech companies in Europe. Microsponge will also appeal to the cosmetic market (e.g. plastic surgery and fillers), which is poised to grow at a fast pace of 8% annually.

www.nanofaber.com

Team member(s)

Your request has been sent
Join this organization
Your request has been sent

Our network

Your request has been sent
Join this network
Your message has been sent

Certifications

InvestHorizon - Accelerated
The InvestHorizon Accelerated label is for selected deep tech companies from the accelerator programme to facilitate series A funding.  This quality label is a guarantee for investors to find high standard project proposals from European SMEs with growth potential. InvestHorizon is a programme financed by the European Commission in association with Eureka to foster investment readiness.
454 Entities

Communities

InvestHorizon
InvestHorizon is an accelerator programme designed to facilitate the access to Series A funding for selected DEEP TECH companies.
2672 Members